Indaptus Therapeutics

INDP · NASDAQ

$2.96+$0.23 (+8.42%)TodayMarket closed ·
Prev close $2.73

Latest news

  • NewsAvi Kapoor

    Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday

  • NewsAvi Kapoor

    Crude Oil Down 3%; Kroger Shares Gain After Upbeat Q2 Earnings

  • NewsAvi Kapoor

    Frequency Electronics, ACV Auctions, HP And Other Big Stocks Moving Higher On Friday

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseGlobe Newswire

    Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseGlobe Newswire

    Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

  • News

    Market-Moving News for December 24th

  • NewsShivdeep Dhaliwal

    Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today

  • Press releaseGlobe Newswire

    Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit

  • Press releaseGlobe Newswire

    Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

  • NewsAvi Kapoor

    Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    Indaptus Therapeutics Provides Clinical Update

  • Press releaseGlobe Newswire

    Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants

  • Press releasePRNewswire

    Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices

  • NewsAvi Kapoor

    Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.